Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters

Ram A. Pathak, Gregory A. Broderick, Todd C. Igel, Steven P. Petrou, Paul R. Young, Michael J. Wehle, Michael G. Heckman, Nancy N. Diehl, Emily R. Vargas, Kandarp Shah, David D. Thiel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective To compare the frequency of postoperative encounters in the 30-day and 90-day postoperative periods for various bladder outlet obstruction surgical therapies. Materials and Methods All patients who underwent transurethral resection of the prostate (TURP), GreenLight laser photovaporization of the prostate (GL-PVP) (American Medical Systems Inc.), and holmium laser enucleation of the prostate (HoLEP) from January 1, 2012 to December 31, 2014 were followed for 6 months postoperatively. All postoperative encounters such as patient calls or questions, catheter exchanges or removals, and hospital-based readmissions or emergency department visits were recorded in the electronic medical record. Results Two hundred and ninety-one consecutive patients underwent outlet procedures during the study period: TURP (N = 199; mean age, 71 years; mean body mass index [BMI], 28.5), HoLEP (N = 60; mean age, 68 years; mean BMI, 28.1), or GL-PVP (N = 32; mean age, 72 years; mean BMI, 29.3). No statistically significant difference was observed for age, BMI, preoperative American Urological Association symptom score, or preoperative maximum flow velocity between the 3 groups. Thirty-day postoperative encounters differed significantly between the 3 surgery types (P < .001). Specifically, there were fewer encounters within 30 days of surgery for TURP compared to both HoLEP (≥1 encounter: TURP = 48.7%, HoLEP = 66.7%; P = .006) and GL-PVP (≥1 encounter: TURP = 48.7%, GL-PVP = 93.7%; P < .001). The number of encounters within 90 days postoperatively was also significantly lower for TURP patients (P < .001). Conclusion TURP results in fewer postoperative encounters in both the 30-day and 90-day postoperative periods compared to HoLEP and GL-PVP. Laser prostate therapies may place increased burden on clinic staff during the 30-day and 90-day postoperative periods.

Original languageEnglish (US)
Pages (from-to)186-191
Number of pages6
JournalUrology
Volume99
DOIs
StatePublished - Jan 1 2017

Fingerprint

Prostatic Hyperplasia
Prostate
Transurethral Resection of Prostate
Solid-State Lasers
Lasers
Body Mass Index
Postoperative Period
Therapeutics
Urinary Bladder Neck Obstruction
Patient Readmission
Electronic Health Records
Laser Therapy
Ambulatory Surgical Procedures
Hospital Emergency Service
Catheters

ASJC Scopus subject areas

  • Urology

Cite this

Pathak, R. A., Broderick, G. A., Igel, T. C., Petrou, S. P., Young, P. R., Wehle, M. J., ... Thiel, D. D. (2017). Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters. Urology, 99, 186-191. https://doi.org/10.1016/j.urology.2016.10.015

Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters. / Pathak, Ram A.; Broderick, Gregory A.; Igel, Todd C.; Petrou, Steven P.; Young, Paul R.; Wehle, Michael J.; Heckman, Michael G.; Diehl, Nancy N.; Vargas, Emily R.; Shah, Kandarp; Thiel, David D.

In: Urology, Vol. 99, 01.01.2017, p. 186-191.

Research output: Contribution to journalArticle

Pathak, RA, Broderick, GA, Igel, TC, Petrou, SP, Young, PR, Wehle, MJ, Heckman, MG, Diehl, NN, Vargas, ER, Shah, K & Thiel, DD 2017, 'Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters', Urology, vol. 99, pp. 186-191. https://doi.org/10.1016/j.urology.2016.10.015
Pathak, Ram A. ; Broderick, Gregory A. ; Igel, Todd C. ; Petrou, Steven P. ; Young, Paul R. ; Wehle, Michael J. ; Heckman, Michael G. ; Diehl, Nancy N. ; Vargas, Emily R. ; Shah, Kandarp ; Thiel, David D. / Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters. In: Urology. 2017 ; Vol. 99. pp. 186-191.
@article{cf247e94acc645abba3c6da8c252e885,
title = "Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters",
abstract = "Objective To compare the frequency of postoperative encounters in the 30-day and 90-day postoperative periods for various bladder outlet obstruction surgical therapies. Materials and Methods All patients who underwent transurethral resection of the prostate (TURP), GreenLight laser photovaporization of the prostate (GL-PVP) (American Medical Systems Inc.), and holmium laser enucleation of the prostate (HoLEP) from January 1, 2012 to December 31, 2014 were followed for 6 months postoperatively. All postoperative encounters such as patient calls or questions, catheter exchanges or removals, and hospital-based readmissions or emergency department visits were recorded in the electronic medical record. Results Two hundred and ninety-one consecutive patients underwent outlet procedures during the study period: TURP (N = 199; mean age, 71 years; mean body mass index [BMI], 28.5), HoLEP (N = 60; mean age, 68 years; mean BMI, 28.1), or GL-PVP (N = 32; mean age, 72 years; mean BMI, 29.3). No statistically significant difference was observed for age, BMI, preoperative American Urological Association symptom score, or preoperative maximum flow velocity between the 3 groups. Thirty-day postoperative encounters differed significantly between the 3 surgery types (P < .001). Specifically, there were fewer encounters within 30 days of surgery for TURP compared to both HoLEP (≥1 encounter: TURP = 48.7{\%}, HoLEP = 66.7{\%}; P = .006) and GL-PVP (≥1 encounter: TURP = 48.7{\%}, GL-PVP = 93.7{\%}; P < .001). The number of encounters within 90 days postoperatively was also significantly lower for TURP patients (P < .001). Conclusion TURP results in fewer postoperative encounters in both the 30-day and 90-day postoperative periods compared to HoLEP and GL-PVP. Laser prostate therapies may place increased burden on clinic staff during the 30-day and 90-day postoperative periods.",
author = "Pathak, {Ram A.} and Broderick, {Gregory A.} and Igel, {Todd C.} and Petrou, {Steven P.} and Young, {Paul R.} and Wehle, {Michael J.} and Heckman, {Michael G.} and Diehl, {Nancy N.} and Vargas, {Emily R.} and Kandarp Shah and Thiel, {David D.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.urology.2016.10.015",
language = "English (US)",
volume = "99",
pages = "186--191",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Impact of Minimally Invasive Benign Prostatic Hyperplasia Therapies on 30- and 90-Day Postoperative Office Encounters

AU - Pathak, Ram A.

AU - Broderick, Gregory A.

AU - Igel, Todd C.

AU - Petrou, Steven P.

AU - Young, Paul R.

AU - Wehle, Michael J.

AU - Heckman, Michael G.

AU - Diehl, Nancy N.

AU - Vargas, Emily R.

AU - Shah, Kandarp

AU - Thiel, David D.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective To compare the frequency of postoperative encounters in the 30-day and 90-day postoperative periods for various bladder outlet obstruction surgical therapies. Materials and Methods All patients who underwent transurethral resection of the prostate (TURP), GreenLight laser photovaporization of the prostate (GL-PVP) (American Medical Systems Inc.), and holmium laser enucleation of the prostate (HoLEP) from January 1, 2012 to December 31, 2014 were followed for 6 months postoperatively. All postoperative encounters such as patient calls or questions, catheter exchanges or removals, and hospital-based readmissions or emergency department visits were recorded in the electronic medical record. Results Two hundred and ninety-one consecutive patients underwent outlet procedures during the study period: TURP (N = 199; mean age, 71 years; mean body mass index [BMI], 28.5), HoLEP (N = 60; mean age, 68 years; mean BMI, 28.1), or GL-PVP (N = 32; mean age, 72 years; mean BMI, 29.3). No statistically significant difference was observed for age, BMI, preoperative American Urological Association symptom score, or preoperative maximum flow velocity between the 3 groups. Thirty-day postoperative encounters differed significantly between the 3 surgery types (P < .001). Specifically, there were fewer encounters within 30 days of surgery for TURP compared to both HoLEP (≥1 encounter: TURP = 48.7%, HoLEP = 66.7%; P = .006) and GL-PVP (≥1 encounter: TURP = 48.7%, GL-PVP = 93.7%; P < .001). The number of encounters within 90 days postoperatively was also significantly lower for TURP patients (P < .001). Conclusion TURP results in fewer postoperative encounters in both the 30-day and 90-day postoperative periods compared to HoLEP and GL-PVP. Laser prostate therapies may place increased burden on clinic staff during the 30-day and 90-day postoperative periods.

AB - Objective To compare the frequency of postoperative encounters in the 30-day and 90-day postoperative periods for various bladder outlet obstruction surgical therapies. Materials and Methods All patients who underwent transurethral resection of the prostate (TURP), GreenLight laser photovaporization of the prostate (GL-PVP) (American Medical Systems Inc.), and holmium laser enucleation of the prostate (HoLEP) from January 1, 2012 to December 31, 2014 were followed for 6 months postoperatively. All postoperative encounters such as patient calls or questions, catheter exchanges or removals, and hospital-based readmissions or emergency department visits were recorded in the electronic medical record. Results Two hundred and ninety-one consecutive patients underwent outlet procedures during the study period: TURP (N = 199; mean age, 71 years; mean body mass index [BMI], 28.5), HoLEP (N = 60; mean age, 68 years; mean BMI, 28.1), or GL-PVP (N = 32; mean age, 72 years; mean BMI, 29.3). No statistically significant difference was observed for age, BMI, preoperative American Urological Association symptom score, or preoperative maximum flow velocity between the 3 groups. Thirty-day postoperative encounters differed significantly between the 3 surgery types (P < .001). Specifically, there were fewer encounters within 30 days of surgery for TURP compared to both HoLEP (≥1 encounter: TURP = 48.7%, HoLEP = 66.7%; P = .006) and GL-PVP (≥1 encounter: TURP = 48.7%, GL-PVP = 93.7%; P < .001). The number of encounters within 90 days postoperatively was also significantly lower for TURP patients (P < .001). Conclusion TURP results in fewer postoperative encounters in both the 30-day and 90-day postoperative periods compared to HoLEP and GL-PVP. Laser prostate therapies may place increased burden on clinic staff during the 30-day and 90-day postoperative periods.

UR - http://www.scopus.com/inward/record.url?scp=85006877935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006877935&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2016.10.015

DO - 10.1016/j.urology.2016.10.015

M3 - Article

C2 - 27771424

AN - SCOPUS:85006877935

VL - 99

SP - 186

EP - 191

JO - Urology

JF - Urology

SN - 0090-4295

ER -